Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
scientific article
Author/s
author: Massimo Offidani, Albert Oriol, Athanasios Dimopoulos, Gianluca Gaidano, Philippe Moreau, Hartmut Goldschmidt, Antonio Palumbo, Thierry Facon, Heinz Ludwig, Robert Z Orlowski, Katja Weisel, Alexander Suvorov, Wee Joo Chng, Ludek Pour, Roman Hajek, Tomas Pika, Vesselina Goranova-Marinova, Leonard Minuk, Vania Hungria, Heidi H Gillenwater, Nehal Mohamed, Ievgenii I Karamanesht, Laura Rosiñol
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.